Duluth, GA-CIBA Vision has signed an agreement with Optonol Ltd. for the exclusive rights to market a miniature glaucoma shunt in the United States and Canada.
Related Content:
POLL: Will you use biosimilars in your ophthalmic practice?
Ophthalmology set to take the Windy City by storm
Florida appeals court reinstates lawsuit against ophthalmologist
